For the past few years, cannabidiol (CBD) has grown from relative obscurity to being one of the most talked-about topics. The chemical is one of over 100 cannabinoids produced by cannabis, or in this case, hemp, and it’s probably one of the most important finds of the decade. Although most of the research is in its preliminary stages, CBD is said to be a potent and versatile natural medicine.
And if the anecdotal evidence is to be believed, the hemp extract is effective against a variety of medical conditions ranging from chronic pain and high blood pressure to…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.